Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 71-78 , January 2010

Factors associated with death 1 year after lower extremity bypass in Northern New England

Presented at the Society for Clinical Vascular Surgery Thirty-Seventh Annual Symposium, Fort Lauderdale, FL, March 18, 2009.

  • Philip P. Goodney, MD, MS

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebano, NH
    • Corresponding Author InformationReprint requests: Philip P. Goodney, MD, Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon NH 03765
    • ,
  • Brian W. Nolan, MD, MS

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebano, NH
    • ,
  • Andres Schanzer, MD

      Affiliations

    • Section of Vascular Surgery, University of Massachusetts Medical Center, Worcester, Mass
    • ,
  • Jens Eldrup-Jorgensen, MD

      Affiliations

    • Maine Medical Center, Portland, Me
    • ,
  • Andrew C. Stanley, MD

      Affiliations

    • Section of Vascular Surgery, Fletcher Allen Healthcare, Burlington, Vt
    • ,
  • David H. Stone, MD

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebano, NH
    • ,
  • Donald S. Likosky, PhD

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebano, NH
    • ,
  • Jack L. Cronenwett, MD

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebano, NH
    • ,
  • Vascular Study Group Of Northern New England

Received 22 May 2009 ,Accepted 24 July 2009.

References 

  1. Nowygrod R, Egorova N, Greco G, et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg. 2006;43:205–216
  2. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. PREVENT III Investigators Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742–751discussion 51
  3. Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg. 2007;45:944–952
  4. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ. Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication: results from a prospective outcomes study. J Vasc Surg. 2000;31:93–103
  5. Comerota AJ, Weaver FA, Hosking JD, Froehlich J, Folander H, Sussman B, et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg. 1996;172:105–112
  6. Goodney PP, Likosky DL, Cronenwett JL. Predicting amputation or graft occlusion after lower extremity bypass. J Vasc Surg. 2009;49:1431–1439.e1
  7. Goodney PP, Likosky DS, Cronenwett JLVascular Study Group of Northern New England. Predicting ambulation status one year after lower extremity bypass. J Vasc Surg. 2009;49:1431–1439.e1
  8. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J, Stanley AC, Nolan BW Vascular Study Group of Northern New England. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg. 2007;46:1093–1101discussion 101-2
  9. Goodney PP, Likosky DS, Cronenwett JLVascular Study Group of Northern New England. Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg. 2008;48:1139–1145
  10. Antolini L, Boracchi P, Biganzoli E. A time-dependent discrimination index for survival data. Stat Med. 2005;24:3927–3944
  11. Handbook of Statistics, Volume 27: Epidemiology and Medical Statistics. In:  Rao CR,  Miller JP,  Rao DC editor. New York: Elsevier; 2008;
  12. Nugent WC. Clinical applications of risk-assessment protocols in the management of individual patients. Ann Thorac Surg. 1997;64(6 Suppl):S68–S72discussion S80-2
  13. O'Connor GT, Birkmeyer JD, Dacey LJ, Quinton HB, Marrin CA, Birkmeyer NJ, et al. Results of a regional study of modes of death associated with coronary artery bypass grafting (Northern New England Cardiovascular Disease Study Group). Ann Thorac Surg. 1998;66:1323–1328
  14. Holman WL, Sansom M, Kiefe CI, Peterson ED, Hubbard SG, Delong JF, et al. Alabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiative. Ann Surg. 2004;239:99–109
  15. Scott IA, Eyeson-Annan ML, Huxley SL, West MJ. Optimising care of acute myocardial infarction: results of a regional quality improvement project. J Qual Clin Pract. 2000;20:12–19
  16. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, et al. Northern New England Cystic Fibrosis Consortium Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol. 2002;33:99–105
  17. O'Grady MA, Gitelson E, Swaby RF, Goldstein LJ, Sein E, Keeley P, et al. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative. J Natl Compr Canc Netw. 2007;5:875–882
  18. Nolan BW, Finalyson S, Tosteson A, Powell RJ, Cronenwett JL. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease–decision analysis. J Vasc Surg. 2007;45:1179–1184
  19. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. BASIL trial participants Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. [see comment] Lancet. 2005;366:1925–1934
  20. Hirsch AT. Treatment of peripheral arterial disease–extending “intervention” to “therapeutic choice”. [see comment] N Engl J Med. 2006;354:1944–1947
  21. McQuade K, Gable D, Hohman S, Pearl G, Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009;49:109–115
  22. Kalbaugh CA, Taylor SM, Cull DL, Blackhurst DW, Gray BH, Langan EM, et al. Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: a 6-month report. J Vasc Surg. 2004;39:1268–1276
  23. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–1471
  24. Taylor SM, Cull DL, Kalbaugh CA, Cass AL, Harmon SA, Langan EM, et al. Critical analysis of clinical success after surgical bypass for lower-extremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment. J Am Coll Surg. 2007;204:831–838discussion 838-9
  25. Taylor SM, Kalbaugh CA, Blackhurst DW, Cass AL, Trent EA, Langan EM, et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg. 2006;44:747–755discussion 755-6

 Dr. Goodney's work was supported by a Peripheral Vascular Surgery Society Academic Award and a Society of Vascular Surgery Clinical Seed Grant. The Vascular Study Group of Northern New England is supported by a grant by from the Center for Medicare and Medicaid Services (CMS), under Cooperative Agreement Award number 18-C-24 91674/1/01.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01660-7

doi: 10.1016/j.jvs.2009.07.123

Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 71-78 , January 2010

Article Tools

* Image Usage & Resolution